window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI in clinical trials

  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Regulatory Affairs

    Transitioning to risk-based clinical trial management under ICH E6(R3)

    Risk-based quality management (RBQM) is becoming central to clinical trial [...]

    February 16, 2026
  • CDMOs & Manufacturing,Clinical Trials,Data Management,Technology and platforms

    PSI launches AI platform to improve clinical trial site selection and enrolment

    PSI CRO has launched SYNETIC, an AI-powered semantic knowledge platform [...]

    February 2, 2026
  • Artificial Intelligence,Digital Health,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    CluePoints names Sinead Godkin CPO to scale global workforce

    CluePoints has appointed Sinead Godkin as chief people officer, strengthening [...]

    January 14, 2026
  • Clinical Development,Clinical studies,Clinical Trials,Data Management,Digital Health,Drug Development,Regulatory Affairs,Technology and platforms

    CluePoints: how proactive oversight and AI are reshaping clinical trial data management

    Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

    January 7, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Technology and platforms

    Medable launches AI agent to automate trial master file workflows

    Medable has launched a new artificial intelligence-powered agent designed to [...]

    January 7, 2026
  • Artificial Intelligence,Clinical Trials,Data Management,Digital Health,Patient Centricity

    Nine ladies dancing: uMotif – patient-centric trials and AI take centre stage in 2026

    As part of Discover Pharma’s 12 days of Christmas series, [...]

    December 22, 2025
  • Artificial Intelligence,Clinical Trials,Real world evidence,Research & Development

    AI in research and clinical trials: Speed, accuracy, and a smarter future

    AI is rapidly transforming how clinical trials are designed, run, [...]

    July 17, 2025
  • Clinical Development,Clinical Trials,Patient Centricity

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    July 10, 2025
  • Artificial Intelligence,Clinical Trials,Regulatory Affairs

    Advarra launches industry council to guide responsible AI use in clinical trials

    A new industry council aims to shape best practices for [...]

    June 24, 2025
  • Artificial Intelligence,Clinical Trials,Technology and platforms

    RBQMLive returns in 2025 with agenda on regulation, ROI and AI in clinical trials

    CluePoints releases full speaker lineup for free virtual event focused [...]

    June 23, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top